- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07390812
Respiratory Transition Without Continuous Positive Airway Pressure
February 25, 2026 updated by: Hackensack Meridian Health
Respiratory Transition Without Continuous Positive Airway Pressure in Term Infants With Mild Respiratory Distress: A Pilot Study
The primary aim of this research project is to determine if term neonates (37:0 to 41:6 weeks' gestational age) with mild respiratory distress can safely transition without continuous positive airway pressure (CPAP).
The secondary aim is to determine the incidence of pneumothorax (PTX) for all term neonates assessed to have mild respiratory distress in the delivery room (DR).
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Hackensack Univeristy Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Full term infants (37 weeks + 0days to 41 weeks +6days gestational age)
- Born via scheduled c-sections without labor
- Who develop mild respiratory distress, defined as nasal flaring or, intermittent grunting, and/or mild retractions and/or +/- mild tachypnea ( respiratory rate 61-90).
Exclusion Criteria:
- Moderate to severe respiratory distress (continuous grunting, or moderate retractions or respiratory rate greater than 90 breaths per minute),
- need for positive pressure ventilation (PPV) or advanced resuscitation in the first 5 minutes of life,
- meconium stained amniotic fluid,
- major congenital anomalies or chromosomal abnormalities.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard of care
Continuous positive airway pressure (CPAP) is administered for mild respiratory distress
|
CPAP administration as per standard of care
|
|
Experimental: Watchful waiting
Neonates with mild respiratory distress are observed for 20 minutes, and CPAP is administered at 25 minutes of life if respiratory distress continues or earlier if moderate to severe respiratory distress occurs
|
Allowing transition without CPAP administration was assessed at 25 minutes of life
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Need for CPAP use at 25 minutes of life
Time Frame: At 25 minutes post birth (after 20 minutes of observation)
|
Babies with mild respiratory distress will be observed for 20 minutes (randomized at 5 minutes of life) using a pulse oximeter (per institutional post-resuscitation care guidelines) and under the study team's direct observation. The active cohort will not receive CPAP unless respiratory distress worsens. |
At 25 minutes post birth (after 20 minutes of observation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of pneumothorax in neonates
Time Frame: Within 6 hours of life
|
Number of babies with pneumothorax in neonates as assessed by a chest ultrasound.
|
Within 6 hours of life
|
|
NICU (Neonatal Intensive Care Unit) admission during hospital stay
Time Frame: Hospital day (from birth to discharge)
|
Number of babies admitted to the NICU for respiratory distress during the initial hospital stay (on average, 1-4 days).
|
Hospital day (from birth to discharge)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nicole Spillane, MD, Hackensack Meridian Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 11, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
January 21, 2026
First Submitted That Met QC Criteria
January 29, 2026
First Posted (Actual)
February 5, 2026
Study Record Updates
Last Update Posted (Actual)
February 27, 2026
Last Update Submitted That Met QC Criteria
February 25, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro2022-0654
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Respiratory Distress
-
NuvOx LLCRecruitingMild Respiratory DistressCanada
-
Vantive Health LLCBaxter Healthcare CorporationCompletedMild to Moderate Acute Respiratory Distress SyndromeFrance
-
University Hospital, CaenNot yet recruitingAcute Respiratory Distress Syndrom
-
PT. Prodia Stem Cell IndonesiaRumah Sakit Pusat Angkatan Darat Gatot SoebrotoRecruitingAcute Respiratory Distress SyndromeIndonesia
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruiting
-
Fayoum UniversityNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Ain Shams UniversityRecruitingAcute Respiratory Distress Syndrome (ARDS)Egypt
-
The Fourth Affiliated Hospital of Zhejiang University...Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Staidson (Beijing) Biopharmaceuticals Co., LtdRecruitingAcute Respiratory Distress Syndrome (ARDS)China
Clinical Trials on CPAP
-
Centre Hospitalier Intercommunal CreteilPr Xavier DURRMEYERNot yet recruitingNeonatal Respiratory DistressFrance
-
State Key Laboratory of Respiratory DiseaseCompletedSleep Apnea, Obstructive | Continuous Positive Airway Pressure | PolysomnographyChina
-
University of ZurichSwiss National Science FoundationCompleted
-
Chinese University of Hong KongCompleted
-
The Hospital for Sick ChildrenCompletedObesity | Cardiovascular Disease | Obstructive Sleep Apnea | Sleep DisordersCanada
-
Federal University of São PauloRecruitingObstructive Sleep Apnea (OSA)Brazil
-
Krishna M. SundarCompleted
-
University Hospital, GrenobleCompleted
-
University Hospital, LilleCompletedSleep Apnea Syndromes | Epilepsies, PartialFrance
-
Ohio State UniversityCompletedHeart Failure | Obstructive Sleep Apnea | Heart Failure, CongestiveUnited States